期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-FDG PET/CT全身肿瘤代谢负荷参数在非小细胞肺癌患者预后评估中的应用 被引量：7

下载PDF
导出
摘要 肺癌患者治疗前的预后评估对制定合理的治疗方案至关重要。^(18)F-FDG PET/CT作为分子影像检查手段,能有效地反映患者的肿瘤代谢负荷,其中全身肿瘤代谢体积(whole-body metabolic tumor volume,MTVwb)及全身病灶总糖酵解值(whole-body total lesion glycolysis,TLGwb)作为全身肿瘤代谢负荷参数,在评价预后方面有很好的应用前景。
作者 吕律 吴宁
机构地区 中国医学科学院肿瘤医院PET-CT中心影像诊断科
出处 《癌症进展》 2016年第1期26-28,31,共4页 Oncology Progress
基金 北京市科技计划课题"首都临床特色应用研究"专项(Z131107002213015)
关键词 肺癌 正电子发射断层成像 肿瘤代谢体积 病灶总糖酵解值 预后评估
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1Traynor AM, Schiller JH. Systemic treatment of advanced non-small cell lung cancer[J]. Drugs Today(Barc), 2004, 40 (8): 697-710.
  • 2American Cancer Society. Cancer Facts & Figures 2015. At- lanta: American Cancer Society; 2015.
  • 3Goldstraw P, Ball D, Jett JR, et al. Non-small-cell lung can- cer[J]. Lancet, 2011, 378(9804): 1727-1740.
  • 4Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours[J]. J Tho- rac Oncol, 2007, 2(8): 706-714.
  • 5Edge S, Byrd DR, Compton CC, et al. AJCC cancer staging handbook. From the AJCC cancer staging manual, 7th ed. New York: Springer; 2010.
  • 6MacManus M, Nestle U, Rosenzweig KE, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert re- port 2006-2007[J]. Radiother Oncol, 2009, 91(1): 85-94.
  • 7Zhong X, Yu J, Zhang B, et al. Using l+F-fluorodeoxyglu- cose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus[J]. Int J Radiat Oncol Biol Phys, 2009, 73 (1): 136-141.
  • 8Yaremko B, Riauka T, Robinson D, et al. Threshold modifi- cation for tumour imaging in non-small-cell lung cancer us- ing positron emission tomography[J]. Nucl Med Commun, 2005, 26(5): 433-440.
  • 9Cheebsumon P, Yaqub M, van Velden FH, et al. Impact of [ 18F] FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation meth- odology[J]. Eur J Nucl Med Mol Imaging, 2011, 38(12): 2136-2144.
  • 10Paulino AC, Koshy M, Howell R, et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensi- ty- modulated radiotherapy for head-and-neck cancer[J]. Int J Radiat Oncol Biol Phys, 2005, 61(5): 1385-1392.

同被引文献94

  • 1石远凯,牛奕.美国国家综合癌症网非小细胞肺癌治疗指南2007年第一版介绍[J].中华肿瘤杂志,2007,29(10):799-800. 被引量：35
  • 2ZHENG R,ZENG H,ZHANG S,et al.National estimates of cancer prevalence in China,2011[J].Cancer Lett,2016,370(1):33-38.
  • 3PAUL A,JEFFREY B.Stereotactic body radiation therapy for stage I non-small cell lung cancer[J].Thorac Surg Clin,2016,26(3):261-169.
  • 4SHINYA H,HIDEKAZU T,HIROAKI H.Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non -small cell lung cancer : Evaluation of mass -like fibrosis [J].Thoracic Cancer,2015,6(2):186-193.
  • 5JfiRfiMIE C,SfiBASTIEN T,BERNARD D,et al.Areas of high 18F -FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer[J].J Nuclear Med,2015,26(2);196-203.
  • 6MASAHIKO A,HIROYOSHI A,MARIKO S,et al.Impact of pretreatment whole -tumor perfusion computed tomography and 18F -fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy [J].J Radia Res,2016,57(s1):1-8.
  • 7HIDEKAZU T,SHINYA H,HIROAKI H.Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy [J].Asia-Pacific Journal of Clinical Oncol,2016,12(1): e113-e117.
  • 8NA FF,WANG JW,LI C,et al.Primary tumor standardized uptake value measured on F18- Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non -small -cell lung cancer receiving radiotherapy : meta-analysis[J].Thorac Oncol.2014,9(6):834-42.
  • 9YOKO S,ATSUSHI N,HIROSHI 0,et al.Value of dual time point F -18 FDG -PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non -small cell lung cancer treated with stereotactic body radiation therapy [J].European Journal of Radiology,2012,81(11):3530-3534.
  • 10PIERRE L,ZSOLT U,PHILIPPE C,et al.FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy [J].Eur J Nucl Med Mol Imaging,2016,43(8):1453-1460.

引证文献7

二级引证文献43

癌症进展
2016年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部